Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Analysis of the NOD2/CARD15 Gene in Patients Affected with the Aseptic Abscesses Syndrome with or without Inflammatory Bowel Disease

Authors: Marc François Jean André, Olivier Aumaître, Jean-Charles Piette, Gilles Grateau, Marie-Céleste Cardoso, Lemlih Ouchchane, Jean-Louis Kémény, Bernard Dastugue, Marc Delpech, Isabelle Creveaux

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

Objectives

NOD2/CARD15 is a susceptibility gene for Crohn’s disease (CD). It is also involved, via different mutations, in the Blau syndrome. The syndrome of aseptic abscesses (AA) is characterized by visceral sterile collections of mature neutrophils that do not respond to antibiotics but regress quickly with corticosteroids. It is associated in two cases out of three with inflammatory bowel disease (IBD), and in particular with CD. We wanted to assess if changes on gene NOD2/CARD15 could contribute to the development of AA in patients with and without IBD.

Methods

Seventeen unrelated patients with AA from the French national register were genotyped for c.802C>T (p.Pro268Ser) and the three main CD associated variants, c.2104C>T (p.Arg702Trp), c.2722G>C (p.Gly908Arg) and c.3019_3020insC (p.Leu1007fsX1008), and 16 were screened for the 11 coding exons of NOD2/CARD15.

Results

The main variants associated with CD were found at a similar frequency in patients free of IBD and in those with CD. There was no significant difference in the main variants between patients with CD and those without IBD in our study and patients with CD and controls, respectively, from a large study of an ethnically similar population. No rare variant was found. A significant association between carriers of the silent variant c.1377 C>T and markers of severity of AA was observed.

Conclusions

These results suggest that the emergence of AA is not closely related to gene NOD2/CARD15. NOD2/CARD15 and other susceptibility genes might enhance the expression of AA as the result of a combination of polymorphisms.
Literature
1.
go back to reference André M, Aumaître O, Marcheix JC, Piette JC (1995) Aseptic systemic abscesses preceding diagnosis of Crohn’s disease by three years. Dig Dis Sci 40:525–527PubMedCrossRef André M, Aumaître O, Marcheix JC, Piette JC (1995) Aseptic systemic abscesses preceding diagnosis of Crohn’s disease by three years. Dig Dis Sci 40:525–527PubMedCrossRef
2.
go back to reference Andre MF, Piette JC, Kemeny JL, Ninet J, Jego P, Delevaux I, Wechsler B, Weiller PJ, Frances C, Bletry O, Wismans PJ, Rousset H, Colombel JF, Aumaitre O, and the French Study Group on Aseptic Abscesses (2007) Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine 86:145–161PubMedCrossRef Andre MF, Piette JC, Kemeny JL, Ninet J, Jego P, Delevaux I, Wechsler B, Weiller PJ, Frances C, Bletry O, Wismans PJ, Rousset H, Colombel JF, Aumaitre O, and the French Study Group on Aseptic Abscesses (2007) Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine 86:145–161PubMedCrossRef
3.
go back to reference André M, Aumaître O, Papo T, Kemeny JL, Vital-Durand D, Rousset H, Ninet J, Pointud P, Charlotte F, Godeau B, Schmidt J, Marcheix JC, Piette JC (1998) Disseminated aseptic abscesses associated with Crohn’s disease : a new entity? Dig Dis Sci 43:420–428PubMedCrossRef André M, Aumaître O, Papo T, Kemeny JL, Vital-Durand D, Rousset H, Ninet J, Pointud P, Charlotte F, Godeau B, Schmidt J, Marcheix JC, Piette JC (1998) Disseminated aseptic abscesses associated with Crohn’s disease : a new entity? Dig Dis Sci 43:420–428PubMedCrossRef
4.
go back to reference Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205PubMedCrossRef Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205PubMedCrossRef
5.
go back to reference Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603PubMedCrossRef Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603PubMedCrossRef
6.
go back to reference Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606PubMedCrossRef Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606PubMedCrossRef
7.
go back to reference Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK (2005) Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kB activation in muramyl dipeptide recognition. J Cell Biol 170:21–26PubMedCrossRef Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK (2005) Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kB activation in muramyl dipeptide recognition. J Cell Biol 170:21–26PubMedCrossRef
8.
go back to reference Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 278:5509–5512PubMedCrossRef Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 278:5509–5512PubMedCrossRef
9.
go back to reference Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G (2003) Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 100:3455–3460PubMedCrossRef Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G (2003) Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 100:3455–3460PubMedCrossRef
10.
go back to reference Watanabe T, Kitani A, Murray PJ, Strober W (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5:800–808PubMedCrossRef Watanabe T, Kitani A, Murray PJ, Strober W (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5:800–808PubMedCrossRef
11.
go back to reference Netea MG, Ferwerda G, de Jong DJ, Girardin SE, Kullberg BJ, van der Meer JW (2005) NOD2 3020insC mutation and the pathogenesis of Crohn’s disease: impaired IL-1β production points to a loss-of-function phenotype. Neth J Med 63:305–308PubMed Netea MG, Ferwerda G, de Jong DJ, Girardin SE, Kullberg BJ, van der Meer JW (2005) NOD2 3020insC mutation and the pathogenesis of Crohn’s disease: impaired IL-1β production points to a loss-of-function phenotype. Neth J Med 63:305–308PubMed
12.
go back to reference Zelinkova Z, Stokkers P, Hommes DW (2005) NOD2 in Crohn’s disease-loss or gain of function mutations? Neth J Med 63:286–287PubMed Zelinkova Z, Stokkers P, Hommes DW (2005) NOD2 in Crohn’s disease-loss or gain of function mutations? Neth J Med 63:286–287PubMed
13.
go back to reference Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857 Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857
14.
go back to reference Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernandez-Vina M, Amos CI, Siminovitch K (2004) CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn’s disease. Am J Gastroenterol 99:306–315PubMedCrossRef Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernandez-Vina M, Amos CI, Siminovitch K (2004) CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn’s disease. Am J Gastroenterol 99:306–315PubMedCrossRef
15.
go back to reference Medici V, Mascheretti S, Croucher PJ, Stoll M, Hampe J, Grebe J, Sturniolo GC, Solberg C, Jahnsen J, Moum B, Schreiber S, Vatn MH (2006) Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Eur J Hum Genet 14:459–468PubMedCrossRef Medici V, Mascheretti S, Croucher PJ, Stoll M, Hampe J, Grebe J, Sturniolo GC, Solberg C, Jahnsen J, Moum B, Schreiber S, Vatn MH (2006) Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Eur J Hum Genet 14:459–468PubMedCrossRef
16.
go back to reference Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, Siminovitch KA, Wordsworth BP, Calin A, Brown MA (2002) Role of NOD2 variants in spondylarthritis. Arthritis Rheum 46:1629–1633PubMedCrossRef Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, Siminovitch KA, Wordsworth BP, Calin A, Brown MA (2002) Role of NOD2 variants in spondylarthritis. Arthritis Rheum 46:1629–1633PubMedCrossRef
17.
go back to reference King K, Sheikh MF, Cuthbert AP, Fisher SA, Onnie CM, Mirza MM, Pattni RC, Sanderson J, Forbes A, Mansfield J, Lewis CM, Roberts RG, Mathew CG (2006) Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat 27:44–54PubMedCrossRef King K, Sheikh MF, Cuthbert AP, Fisher SA, Onnie CM, Mirza MM, Pattni RC, Sanderson J, Forbes A, Mansfield J, Lewis CM, Roberts RG, Mathew CG (2006) Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat 27:44–54PubMedCrossRef
18.
go back to reference Hugot JP, Zouali H, Lesage S (2003) Lessons to be learned from the NOD2 gene in Crohn’s disease. Eur J Gastroenterol Hepatol 15:593–597PubMedCrossRef Hugot JP, Zouali H, Lesage S (2003) Lessons to be learned from the NOD2 gene in Crohn’s disease. Eur J Gastroenterol Hepatol 15:593–597PubMedCrossRef
20.
go back to reference Rosenstiel P, Huse K, Till A, Hampe J, Hellmig S, Sina C, Billmann S, von Kampen O, Waetzig GH, Platzer M, Seegert D, Schreiber S (2006) A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci 103:3280–3285PubMedCrossRef Rosenstiel P, Huse K, Till A, Hampe J, Hellmig S, Sina C, Billmann S, von Kampen O, Waetzig GH, Platzer M, Seegert D, Schreiber S (2006) A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci 103:3280–3285PubMedCrossRef
21.
go back to reference Newman B, Rubin LA, Siminovitch KA (2003) NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener’s granulomatosis. J Rheumatol 30:305–307PubMed Newman B, Rubin LA, Siminovitch KA (2003) NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener’s granulomatosis. J Rheumatol 30:305–307PubMed
22.
go back to reference Miceli-Richard C, Zouali H, Lesage S, Thomas G, Hugot JP, Said-Nahal R, Breban M (2002) CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 46:1405–1406PubMedCrossRef Miceli-Richard C, Zouali H, Lesage S, Thomas G, Hugot JP, Said-Nahal R, Breban M (2002) CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 46:1405–1406PubMedCrossRef
23.
go back to reference Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, Peddle L, Schentag CT, Alderdice CA, Hamilton S, Khraishi M, Tobin Y, Hefferton D, Gladman DD (2003) CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 73:677–681PubMedCrossRef Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, Peddle L, Schentag CT, Alderdice CA, Hamilton S, Khraishi M, Tobin Y, Hefferton D, Gladman DD (2003) CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 73:677–681PubMedCrossRef
24.
go back to reference Nair RP, Stuart P, Ogura Y, Inohara N, Chia NV, Young L, Henseler T, Jenisch S, Christophers E, Voorhees JJ, Nunez G, Elder JT (2001) Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol 117:1671–1672PubMedCrossRef Nair RP, Stuart P, Ogura Y, Inohara N, Chia NV, Young L, Henseler T, Jenisch S, Christophers E, Voorhees JJ, Nunez G, Elder JT (2001) Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol 117:1671–1672PubMedCrossRef
25.
go back to reference Borgiani P, Vallo L, D’Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G (2002) Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol 12:540–542PubMed Borgiani P, Vallo L, D’Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G (2002) Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol 12:540–542PubMed
26.
go back to reference Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE (2005) CARD15 polymorphisms in Behcet’s disease. Scand J Rheumatol 34:233–237PubMedCrossRef Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE (2005) CARD15 polymorphisms in Behcet’s disease. Scand J Rheumatol 34:233–237PubMedCrossRef
27.
go back to reference Newman B, Cescon D, Domenchini A, Siminovitch KA (2004) CD2BP1 and CARD15 mutations are not associated with pyoderma gangrenosum in patients with inflammatory bowel disease. J Invest Dermatol 122:1054–1056PubMedCrossRef Newman B, Cescon D, Domenchini A, Siminovitch KA (2004) CD2BP1 and CARD15 mutations are not associated with pyoderma gangrenosum in patients with inflammatory bowel disease. J Invest Dermatol 122:1054–1056PubMedCrossRef
Metadata
Title
Analysis of the NOD2/CARD15 Gene in Patients Affected with the Aseptic Abscesses Syndrome with or without Inflammatory Bowel Disease
Authors
Marc François Jean André
Olivier Aumaître
Jean-Charles Piette
Gilles Grateau
Marie-Céleste Cardoso
Lemlih Ouchchane
Jean-Louis Kémény
Bernard Dastugue
Marc Delpech
Isabelle Creveaux
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9871-8

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.